APO F43 (Fenofibrate (Micronized) 43 mg)
Pill with imprint APO F43 is Green & White, Capsule-shape and has been identified as Fenofibrate (Micronized) 43 mg. It is supplied by Apotex Corp.
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 43 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO F43
Fenofibrate (Micronized)
- Imprint
- APO F43
- Strength
- 43 mg
- Color
- Green & White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- National Drug Code (NDC)
- 60505-3120
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
sodium lauryl sulfate,
gelatin,
titanium dioxide,
D&C Yellow No. 10,
FD&C Blue No. 2,
shellac,
alcohol,
isopropyl alcohol,
butyl alcohol,
ferrosoferric oxide,
propylene glycol,
ammonia
Note: Inactive ingredients may vary.
More about fenofibrate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (62)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: fibric acid derivatives
Patient resources
- Drug Information
- Fenofibrate (Advanced Reading)
- Fenofibrate and Derivatives Capsules
- Fenofibrate and Derivatives Tablets
- Other brands
- TriCor, Lofibra, Triglide, Lipofen, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.